Bio-Rad Laboratories Inc (BIO)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 2,566,500 | 2,671,260 | 2,802,250 | 2,922,540 | 2,545,630 |
| Total current assets | US$ in thousands | 1,207,100 | 3,048,330 | 3,157,980 | 1,989,090 | 2,139,840 |
| Total current liabilities | US$ in thousands | 467,800 | 522,799 | 568,708 | 680,938 | 631,536 |
| Working capital turnover | 3.47 | 1.06 | 1.08 | 2.23 | 1.69 |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $2,566,500K ÷ ($1,207,100K – $467,800K)
= 3.47
The working capital turnover ratio for Bio-Rad Laboratories Inc has shown fluctuations over the period from December 31, 2020, to December 31, 2024. The ratio increased from 1.69 in 2020 to 2.23 in 2021, indicating that the company generated $2.23 in net sales revenue for each dollar of working capital invested.
However, there was a significant decrease in the ratio in 2022 and 2023, dropping to 1.08 and 1.06, respectively. This suggests a decrease in efficiency in utilizing its working capital to generate sales during these years.
The ratio then rebounded sharply in 2024 to 3.47, which indicates a notable improvement in the efficiency of the company in utilizing its working capital. It implies that Bio-Rad Laboratories Inc was able to generate $3.47 in sales for every dollar invested in working capital during 2024.
Overall, the fluctuation in the working capital turnover ratio for Bio-Rad Laboratories Inc suggests varying levels of operational efficiency in managing its working capital and converting it into sales revenue over the analyzed period.
Peer comparison
Dec 31, 2024